The IRS classifies injectable and oral GLP-1 receptor agonists as qualified medical expenses under both Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA)
PMC 7896253
In most cases, adults may qualify for GLP-1 weight loss medications with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, sleep apnea, or cardiovascular disease
From the PlexusDx Education Hub, an independent side-by-side of two very different GLP-1 weight-management models: Noom and Ro
164, Mar
You should seek professional advice urgently if you experience any of the following symptoms while on any GLP-1 class medication: severe and persistent abdominal pain radiating to the back (a potential sign of pancreatitis), signs of a severe allergic reaction, rapid heart rate, or significant worsening of any pre-existing conditions